Alessandro Sannino
Corporate Officer/Principal presso University of Salento
Patrimonio netto: 2 410 $ in data 31/12/2023
Posizioni attive di Alessandro Sannino
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Salento | Corporate Officer/Principal | 01/09/2000 | - |
Storia della carriera di Alessandro Sannino
Precedenti posizioni note di Alessandro Sannino
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GELESIS HOLDINGS, INC. | Corporate Officer/Principal | 13/01/2022 | 30/10/2023 |
| GELESIS INC | Corporate Officer/Principal | 01/05/2008 | 01/01/2022 |
Academica Life Science SRL
 Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Fondatore | 26/05/2010 | - |
| Presidente | 01/04/2006 | - |
Formazione di Alessandro Sannino
| Università degli Studi di Napoli Federico II | Doctorate Degree |
| University of Washington | Doctorate Degree |
Statistiche
Distribuzione geografica
| Italia | 4 |
| Stati Uniti | 4 |
Posizioni
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
| Founder | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Academica Life Science SRL
Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Commercial Services |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Alessandro Sannino
- Esperienza
